TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biosorbe AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
16
|
68
|
4 |
| Financial expenses |
74
|
38
|
34 |
| Earnings before taxes |
-1,326
|
-920
|
-810 |
| EBITDA |
-1,007
|
-691
|
-566 |
| Total assets |
2,146
|
1,069
|
1,326 |
| Current assets |
309
|
166
|
284 |
| Current liabilities |
789
|
643
|
361 |
| Equity capital |
1,026
|
103
|
573 |
| - share capital |
278
|
85
|
85 |
| Employees (average) |
5
|
5
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.8%
|
9.6%
|
43.2% |
| Turnover per employee |
3
|
14
|
1 |
| Profit as a percentage of turnover |
-8287.5%
|
-1352.9%
|
-20250.0% |
| Return on assets (ROA) |
-58.3%
|
-82.5%
|
-58.5% |
| Current ratio |
39.2%
|
25.8%
|
78.7% |
| Return on equity (ROE) |
-129.2%
|
-893.2%
|
-141.4% |
| Change turnover |
-49
|
64
|
2 |
| Change turnover % |
-76%
|
1727%
|
78% |
| Chg. No. of employees |
0
|
-2
|
2 |
| Chg. No. of employees % |
0%
|
-29%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.